Annik Caliezi | Clinical Trials | Best Researcher Award

Annik Caliezi | Clinical Trials | Best Researcher Award

Ms. Annik Caliezi, Dermatologie Inselspital, Switzerland

Annik Caliezi is a dedicated medical student in her 10th semester of the Master of Medicine program at the University of Bern. She holds a Bachelor’s in Medicine and a bilingual Matura in Economics and Law. With hands-on experience as a nursing assistant at Careanesth and an OR assistant in hand surgery, Annik has also contributed to histology and anatomy education. Her research focuses on Hidradenitis Suppurativa and its impact on sexual quality of life, with publications in MDPI. Fluent in German, English, and French, she holds multiple life support certifications. ๐Ÿ”ฌ๐Ÿ“š

Publication Profile

orcid

Education

Ms. Annik Caliezi ๐ŸŽ“ is currently in the 10th semester of her Master of Medicine at the University of Bern ๐Ÿฅ, where she has been pursuing her studies since 2023. Prior to this, she completed her Bachelor of Medicine (2020โ€“2023) at the same institution, building a strong foundation in medical sciences ๐Ÿ”ฌ. Her academic journey began with a bilingual Matura in Economics and Law ๐Ÿ“šโš–๏ธ at Gymnasium Kirchenfeld Bern (2015โ€“2019), where she developed analytical and interdisciplinary skills. With a passion for medicine and a commitment to excellence, she continues to advance in her medical education and training. ๐Ÿš€

Experience

Ms. Annik Caliezi ๐Ÿฅ has gained diverse work experience in healthcare and beyond. Since May 2024, she has been working as a nursing assistant at Careanesth ๐Ÿฉบ, and since May 2023, she has served as an OR Assistant in Hand Surgery at Permanence Hospital Hirslanden Bern โœ‹๐Ÿฝ๐Ÿ”ฌ. Previously, she assisted in histology and anatomy courses at the University of Bern (10/2022โ€“05/2023) ๐Ÿงซ๐Ÿ“š. Since December 2021, she has been interning at Bahnhofpraxis Wichtrach ๐Ÿš‘. Her earlier experiences include a geriatric rehabilitation internship (2021) ๐Ÿ‘ต๐Ÿผ, a role as a waitress (2019โ€“2020) โ˜•, and an activity therapy internship (2018) ๐Ÿก.

Awards

Ms. Annik Caliezi ๐Ÿฅ has earned several valuable certifications in healthcare and language proficiency. In 2024, she became an Immediate Life Support (ILS) Provider through the European Resuscitation Council ๐Ÿš‘. She also completed the French course “Franรงais pour futur mรฉdecin” (2023) ๐Ÿฉบ๐Ÿ‡ซ๐Ÿ‡ท, enhancing her medical communication skills. Additionally, she holds Basic Life Support (BLS) Provider certifications from 2021 and 2022 ๐Ÿฅ๐Ÿ†˜. Beyond medical training, she achieved Cambridge English Advanced (C1) โ€“ Grade A in 2019 ๐Ÿ“–๐Ÿ‡ฌ๐Ÿ‡ง. These certifications reflect her commitment to excellence in both emergency care and multilingual communication in the medical field. ๐Ÿš€

Research Focus

Ms. Annik Calieziโ€™s research primarily focuses on dermatology ๐Ÿฉบ, with a specific emphasis on hidradenitis suppurativa (HS) ๐Ÿ”ฌ, a chronic inflammatory skin disease. Her work examines the impact of HS on sexual quality of life โค๏ธ, addressing the psychological, emotional, and physical challenges faced by patients. Through her studies, she highlights the burden of HS ๐Ÿค•, emphasizing the need for better patient care, awareness, and treatment strategies ๐Ÿ“ข. Her research contributes to dermatological advancements, aiming to improve both clinical outcomes and overall well-being ๐Ÿ˜Š for individuals affected by this debilitating condition.

Publication Top Notes

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Prof Serefnur Ozturk, Selcuk University Faculty of Medicine, Turkey

Prof. ลžerefnur ร–ztรผrk is a leading expert in Neurology and Neurointensive Care, currently serving as the Head of the Neurology Department at Selcuk University, Turkey. She has held prominent roles including Vice Dean of the Faculty of Medicine (1996-2020) and President of the Turkish Neurological Society (2014-2021). With significant international influence, she contributes to the European Academy of Neurology and World Stroke Organization. She has led pivotal projects and trials in stroke and COVID-19-related neurological care. Prof. ร–ztรผrk is an acclaimed researcher with numerous influential publications in neurology.

Publication Profile

scopus

Education

Prof. Serefnur Ozturk has an impressive educational background. She began her medical studies at Ankara University Medical Faculty, where she earned her degree between 1980 and 1987. Her academic journey continued with a prestigious NATO Fellowship at Arizona University’s Stroke Center in 1993, further enhancing her expertise. In 1998, she advanced her knowledge in neurology and intensive care at Pittsburgh University, where she studied in their renowned Neurology and Intensive Care Department. These experiences have shaped Prof. Ozturk into a leading figure in her field. ๐Ÿฅ๐ŸŽ“๐Ÿง 

Internship and Residencies

Prof. Serefnur Ozturk completed her internship at Ankara University Medical Faculty, where she gained valuable hands-on experience. Following this, she pursued her residency at Ankara Numune Research and Education Hospital, further honing her medical skills. Prof. Ozturk’s dedication to her field is reflected in her board certification, earning the Turkish Neurological Board Council Certificate. This certification recognizes her extensive expertise in neurology, solidifying her status as a trusted professional in her area of specialization. Her journey through internships, residencies, and board certification showcases her commitment to excellence. ๐Ÿฅ๐Ÿ’‰๐Ÿง‘โ€โš•๏ธ๐Ÿง 

Experiences

Prof. Serefnur Ozturk holds numerous prestigious leadership roles in neurology. She served as the President of the Turkish Neurological Society from 2014 to 2021 and is currently a member of various important committees, including the European Academy of Neurology (EAN) COVID-19 Task Force and the World Stroke Organization Global Policy Committee. Additionally, she is the Vice President of the European Environmental Neurology Society and has held positions within the World Federation of Neurology (WFN), including President of the Migrant Neurology Specialty Group. Prof. Ozturk is dedicated to advancing stroke care, cerebrovascular diseases prevention, and diversity in neurology. ๐Ÿง ๐ŸŒ๐Ÿ‘ฉโ€โš•๏ธ๐Ÿฅ

Projects

Prof. Serefnur Ozturk has played a pivotal role in several major clinical trials and registries. She is the Principal Investigator of the EAN ENERGY COVID-19 Registry and the ENSEMBLE study, showcasing her leadership in critical research. Additionally, Prof. Ozturk serves as the National Coordinator for the Turkish COVID-19 Registry, the ENOS Trial, and TICH-2. Her expertise extends to key studies like the PERFORM Study (Phase III), FACT (Phase IV), and NAVIGATE-ESUS, where she also holds significant leadership positions. Her contributions to clinical research have greatly impacted neurology and stroke care. ๐Ÿ”ฌ๐Ÿง ๐ŸŒ๐Ÿ’‰

Research Focus

Prof. ลžerefnur ร–ztรผrk’s research focus lies predominantly in neurology, with a special emphasis on the neurological impacts of COVID-19, ischemic stroke, and innovative prognostic tools like the Selcuk Score. Her work is pivotal in advancing the understanding of how pandemics influence neurological care and the management of post-pandemic risks. Additionally, Prof. ร–ztรผrk contributes to cutting-edge stroke prevention and rehabilitation technologies, including web-based solutions. Her contributions drive progress in neuro-COVID research, stroke management, and global neurological health policies, showcasing her commitment to improving outcomes for patients worldwide. ๐ŸŒ๐Ÿง ๐Ÿ’ป

Publication Top Notes

The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future

Muscle mass as a modifier of stress response in acute ischemic stroke patients

Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers โ€” An updated European Academy of Neurology consensus statement

The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data from 121 Surgically Treated Participants from the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial

General neurology: Current challenges and future implications

Climate Change and Stroke: A Topical Narrative Review